Immunome Inc’s recent filing unveils that its President and CEO SIEGALL CLAY B acquired Company’s shares for reported $0.1 million on Dec 30 ’25. In the deal valued at $21.15 per share,4,729 shares were bought. As a result of this transaction, SIEGALL CLAY B now holds 665,254 shares worth roughly $14.09 million.
Then, Barchas Isaac sold 383,200 shares, generating $8,330,080 in total proceeds. Upon selling the shares at $21.74, the Director now owns 2,031,181 shares.
Before that, SIEGALL CLAY B bought 7,278 shares. Immunome Inc shares valued at $149,053 were divested by the President and CEO at a price of $20.48 per share. As a result of the transaction, SIEGALL CLAY B now holds 860,525 shares, worth roughly $18.23 million.
Truist initiated its Immunome Inc [IMNM] rating to a Buy in a research note published on December 01, 2025; the price target was $36. A number of analysts have revised their coverage, including Goldman’s analysts, who began to cover the stock in late September with a ‘”a Buy”‘ rating. Craig Hallum began covering IMNM with “Buy” recommendation on September 05, 2025. Lake Street started covering the stock on April 02, 2025. It rated IMNM as “a Buy”.
Price Performance Review of IMNM
On Tuesday, Immunome Inc [NASDAQ:IMNM] saw its stock fall -1.94% to $21.18. Over the last five days, the stock has lost -3.86%. Immunome Inc shares have risen nearly 90.81% since the year began. Nevertheless, the stocks have risen 99.44% over the past one year. While a 52-week high of $25.30 was reached on 12/15/25, a 52-week low of $5.15 was recorded on 04/09/25.
Levels Of Support And Resistance For IMNM Stock
The 24-hour chart illustrates a support level at 20.91, which if violated will result in even more drops to 20.65. On the upside, there is a resistance level at 21.65. A further resistance level may holdings at 22.13.
How much short interest is there in Immunome Inc?
A steep rise in short interest was recorded in Immunome Inc stocks on 2025-12-15, growing by 1.55 million shares to a total of 15.88 million shares. Yahoo Finance data shows the prior-month short interest on 2025-11-14 was 14.32 million shares. There was a rise of 9.78%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on November 08, 2024 when Stephens began covering the stock and recommended ‘”an Overweight”‘ rating along with a $30 price target.
